Insider Selling: Quanterix Corp (QTRX) VP Sells 652 Shares of Stock

Quanterix Corp (NASDAQ:QTRX) VP Dawn Mattoon sold 652 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $20.02, for a total transaction of $13,053.04. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Dawn Mattoon also recently made the following trade(s):

  • On Wednesday, May 1st, Dawn Mattoon sold 65 shares of Quanterix stock. The stock was sold at an average price of $22.59, for a total transaction of $1,468.35.
  • On Tuesday, April 2nd, Dawn Mattoon sold 72 shares of Quanterix stock. The stock was sold at an average price of $23.27, for a total transaction of $1,675.44.
  • On Friday, March 1st, Dawn Mattoon sold 75 shares of Quanterix stock. The stock was sold at an average price of $25.00, for a total transaction of $1,875.00.
  • On Tuesday, February 26th, Dawn Mattoon sold 890 shares of Quanterix stock. The stock was sold at an average price of $23.72, for a total transaction of $21,110.80.

Shares of QTRX traded down $0.23 during mid-day trading on Wednesday, hitting $20.85. 301 shares of the company’s stock were exchanged, compared to its average volume of 79,095. Quanterix Corp has a 52 week low of $13.00 and a 52 week high of $26.48. The stock has a market capitalization of $465.25 million, a PE ratio of -14.65 and a beta of 1.28. The company has a current ratio of 3.28, a quick ratio of 2.95 and a debt-to-equity ratio of 0.19.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Monday, March 18th. The company reported ($0.42) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.25) by ($0.17). Quanterix had a negative return on equity of 62.68% and a negative net margin of 83.80%. The business had revenue of $10.88 million for the quarter, compared to the consensus estimate of $9.69 million. Equities research analysts predict that Quanterix Corp will post -1.57 earnings per share for the current fiscal year.

QTRX has been the topic of several recent research reports. Canaccord Genuity reaffirmed a “buy” rating and set a $29.00 target price on shares of Quanterix in a report on Friday, March 8th. Zacks Investment Research raised shares of Quanterix from a “sell” rating to a “hold” rating in a report on Thursday, May 9th. Finally, ValuEngine raised shares of Quanterix from a “hold” rating to a “buy” rating in a report on Thursday, January 31st.

Institutional investors and hedge funds have recently made changes to their positions in the company. BNP Paribas Arbitrage SA increased its holdings in shares of Quanterix by 5,803.2% during the first quarter. BNP Paribas Arbitrage SA now owns 1,830 shares of the company’s stock worth $47,000 after purchasing an additional 1,799 shares during the period. Citigroup Inc. increased its holdings in shares of Quanterix by 50.3% during the first quarter. Citigroup Inc. now owns 2,661 shares of the company’s stock worth $69,000 after purchasing an additional 891 shares during the period. Macquarie Group Ltd. bought a new position in shares of Quanterix during the fourth quarter worth approximately $100,000. Bank of Montreal Can increased its holdings in shares of Quanterix by 3,159.2% during the first quarter. Bank of Montreal Can now owns 3,911 shares of the company’s stock worth $101,000 after purchasing an additional 3,791 shares during the period. Finally, Bank of America Corp DE increased its holdings in shares of Quanterix by 386.4% during the fourth quarter. Bank of America Corp DE now owns 5,817 shares of the company’s stock worth $107,000 after purchasing an additional 4,621 shares during the period. 51.76% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: Quanterix Corp (QTRX) VP Sells 652 Shares of Stock” was first posted by WKRB News and is owned by of WKRB News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.wkrb13.com/2019/05/15/insider-selling-quanterix-corp-qtrx-vp-sells-652-shares-of-stock.html.

About Quanterix

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.

Read More: What are benefits of a growth and income fund?

Insider Buying and Selling by Quarter for Quanterix (NASDAQ:QTRX)

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.